Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer | 45,000 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-15 Option Award | 2025-01-16 08:04 am | N/A 2035-01-15 | BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2025-01-16 08:03 am | N/A 2033-12-08 | BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director | 0 | $0 | 15,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:55 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 13,500 | $0 | 13,500 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-15 6:14 pm | N/A 2034-02-15 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 54,000 | $0 | 54,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 4:26 pm | N/A 2033-06-12 | REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer | 135,000 | $0 | 135,000 (Direct) | View |